Mpm Asset Management as of June 30, 2014
Portfolio Holdings for Mpm Asset Management
Mpm Asset Management holds 14 positions in its portfolio as reported in the June 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Radius Health | 25.5 | $76M | 5.8M | 13.00 | |
Epizyme | 25.3 | $75M | 2.4M | 31.12 | |
Portola Pharmaceuticals | 12.0 | $36M | 1.2M | 29.18 | |
Aratana Therapeutics | 11.0 | $33M | 2.1M | 15.61 | |
Trivascular Technologies | 9.3 | $28M | 1.8M | 15.57 | |
Celladon | 5.8 | $17M | 1.1M | 16.02 | |
Conatus Pharmaceuticals | 3.6 | $11M | 1.2M | 9.11 | |
PharmAthene | 3.0 | $9.0M | 6.3M | 1.41 | |
Verastem | 2.5 | $7.4M | 817k | 9.06 | |
Pacira Pharmaceuticals (PCRX) | 1.2 | $3.6M | 39k | 91.86 | |
EnteroMedics | 0.6 | $1.7M | 1.1M | 1.56 | |
Sangamo Biosciences (SGMO) | 0.1 | $343k | 23k | 15.25 | |
Mast Therapeutics | 0.1 | $331k | 525k | 0.63 | |
Macrogenics (MGNX) | 0.0 | $69k | 3.2k | 21.78 |